D-1289-2020 Class III Terminated
FDA drug recall D-1289-2020 was initiated by AVKARE Inc. on May 28, 2020 and is designated Class III. Reason for recall: Presence of Foreign Substance consistent with granules from desiccant packs used during storage The recall status is terminated (terminated Oct 22, 2021). Affected quantity: 4124 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 10, 2020
- Initiation Date
- May 28, 2020
- Termination Date
- Oct 22, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4124 bottles
Product description
Lamotrigine Tablets, USP, 150 mg, Rx Only, a) 60 count Bottle, NDC 42291-368-60, b) 500 count Bottle, NDC 42291-368-50, Manufactured for: AvKARE, Inc. Pulaski, TN 38478.
Reason for recall
Presence of Foreign Substance consistent with granules from desiccant packs used during storage
Distribution pattern
Nationwide in the U.S.
Code information
Lot #: a) 25634, b) 25633; Exp. 09/30/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1289-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026